The sensitivity to anticonvulsants and anesthetics of Ca 2ϩ currents arising from ␣1G and ␣1H subunits was examined in stably transfected HEK293 cells. For comparison, in some cases blocking effects on dorsal root ganglion (DRG) T currents were also examined under identical ionic conditions. The anticonvulsant, phenytoin, which partially blocks DRG T current, blocked ␣1G current completely but with weaker affinity (ϳ140 M). Among different cells, ␣1H current exhibited either of two responses to phenytoin. In one subpopulation of cells, phenytoin produced a partial, higher affinity block (IC 50 ϳ7.2 M, maximum block ϳ43%) similar to that in DRG neurons. In other cells, phenytoin produced complete, but lower affinity, blockade (IC 50 ϳ138 M, maximum block ϳ89%). Another anticonvulsant, ␣-methyl-␣-phenylsuccinimide (MPS), blocked DRG current partially, but blocked both ␣1G and ␣1H currents completely with weaker affinity (ϳ1.7 mM). These data suggest that higher affinity blockade of T-type currents by phenytoin and MPS may require additional regulatory factors that can contribute to native T-type channels. In contrast, anesthetics blocked all T current variants similarly and completely. Block of ␣1G current by anesthetics had the following order of potency: propofol (IC 50 ϳ20.5 M) Ͼ etomidate (ϳ161 M) ϭ octanol (ϳ160 M) Ͼ isoflurane (ϳ277 M) Ͼ ketamine (ϳ1.2 mM), comparable with results on DRG T currents. Barbiturates completly blocked ␣1G currents with potency [thiopental (ϳ280 M), pentobarbital (ϳ310 M), phenobarbital (ϳ1.54 mM)] similar to that in DRG cells. The effects of propofol, octanol, and pentobarbital on ␣1H currents were indistinguishable from effects on ␣1G currents.
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Among voltage-dependent Ca 2ϩ channels, T-type channels, by virtue of their activation at relatively negative potentials, are believed to play a crucial role in the control of cell firing rates (Llinas, 1988; Huguenard, 1996) . Major proposed roles for T-type channels in neurons include promotion of Ca 2ϩ -dependent burst firing, low-amplitude intrinsic neuronal oscillations, promotion of Ca 2ϩ entry, and boosting of synaptic signals (Huguenard, 1996) . Furthermore, T-type currents appear to play a role in seizure susceptibility and initiation (Chung et al., 1993; Huguenard and Prince, 1994; Tsakiridou et al., 1995) .
T currents in different native tissues appear to share a number of common features that help distinguish them from high-voltage-activated Ca 2ϩ currents. These include relative permeation by Ca 2ϩ and Ba 2ϩ (Carbone and Lux, 1987a,b) , more negative activation voltages (Carbone and Lux, 1984) , similarity in deactivation and inactivation kinetics, and generally a greater sensitivity to blockade by Ni 2ϩ over Cd 2ϩ (Fox et al., 1987) . However, despite these similarities, differences in both kinetic behavior of some native T currents (Huguenard and Prince, 1992; Huguenard et al., 1993) and pharmacological properties (e.g., Herrington and Lingle, 1992 ; review by Huguenard, 1996; Todorovic and Lingle, 1998) have been observed. Diversity in native T-type Ca 2ϩ channel function might arise from tissue-specific expression of the ␣1G, ␣1H, and ␣1I subunits now known to encode T-type Ca 2ϩ channels Cribbs et al., 1998) . For example, the ␣1H subunit appears to be the primary contributor to T-type current in sensory neurons (Talley et al., 1999) . In addition, T-like Ca 2ϩ currents in native cells might also arise from other mechanisms. For example, Meir and Dolphin (1998) reported that multiple subunits of high-voltage-activated (HVA) channels can under certain conditions give rise to T-type currents.
One difficulty in evaluating pharmacological studies of T currents in native cells is that for some agents the conditions under which a compound has been investigated have not been identical. Similarly, in many cases, full concentrationresponse curves for effects on T currents have not been defined. As a consequence, it has not been possible to determine This work was supported by National Institutes of Health Grants GM-47969 (to C.L.) and HL58728 (to E.P.R.). S.T. was the recipient of a Foundation for Anesthesia Education and Research/Abbott Laboratories New Investigator Award.
the extent to which different T currents share a particular pharmacological profile or represent distinct current variants. Incomplete concentration-response information also makes it unclear whether effects seen in vitro correlate with the concentrations of a particular drug in plasma necessary to achieve therapeutic effects. In those cases where more complete information about the sensitivity of a T current to particular pharmacological agents is available, some clear differences in pharmacological properties are revealed. Two sets of agents for which quite disparate blocking effects on T currents among different cells have been reported include divalent cations, including Ni 2ϩ and Cd 2ϩ (Kaneda and Akaike, 1989; Herrington and Lingle, 1992; Ye and Akaike, 1993; Todorovic and Lingle, 1998) and anticonvulsants (Herrington and Lingle, 1992; Gross et al., 1997; Todorovic and Lingle, 1998) . With the availability of the cloned ␣1G, ␣1H, and ␣1I subunits encoding T-type currents, it is now possible to assess directly the pharmacological sensitivities of the ␣ subunits.
Toward this end, we examine here the sensitivity of ␣1G and ␣1H currents to anesthetics and anticonvulsants. Where the blocking effect of a compound is found to differ from previously described effects on T currents in dorsal root ganglion (DRG) neurons , we have re-examined the blocking effect of that compound on DRG T current under identical ionic and recording conditions. We observed that, for the anesthetics examined, blocking effects are essentially identical for ␣1G, ␣1H, and native DRG T currents. However, for the anticonvulsants, phenytoin and ␣-methyl-␣-phenylsuccinimide (MPS), blockade of ␣1G current differed from blockade of native DRG T current. Specifically, in contrast to blockade of DRG T current where block was of higher affinity, but only partial, these agents blocked ␣1G current completely but with lower affinity. Furthermore, for ␣1H current, phenytoin produced two different kinds of responses, one similar to its effects on DRG T current and one similar to the effects on ␣1G current. No physiological differences in the ␣1H currents underlying these responses were observed. This raises the possibility that either post-translational modification of ␣1H subunits or an additional accessory subunit may contribute to the pharmacological sensitivity of native T-type currents.
Experimental Procedures
Cell Preparation. HEK 293 cells were stably transfected with either ␣1G or ␣1H constructs as described previously . Cells were typically used 1 to 3 days after plating. Average cell capacitance (C m ) was 20.9 Ϯ 5.7 pF, and the average series resistance (R s ) was 5.29 Ϯ 2.08 (n ϭ 34). For DRG neurons, 100-to 300-g male rats (Sprague-Dawley) were used as we described elsewhere . Eight to ten DRG from thoracic and upper lumbar regions were dissected out and incubated at 36°C for 60 to 90 min in Tyrode's solution (140 mM NaCl, 4 mM KCl, 2 mM MgCl 2 , 10 mM glucose, 10 mM HEPES, adjusted to pH 7.4 with NaOH) containing 5 mg/ml collagenase (type I, Sigma Chemical Co., St. Louis, MO) and 5 mg/ml dispase II (Boehringer-Manheim, Indianapolis, IN). Single neuronal cell bodies were obtained by trituration in Tyrode's solution at room temperature. Cells were kept at room temperature and used for electrophysiology within 4 to 6 h from dissociation. For recordings, neuronal cell bodies were plated onto a glass cover-slip and placed in a culture dish that was perfused with external solution. All data were obtained from smaller diameter DRG neurons (21-27 m) without visible processes. The average C m for DRG cells was 14.6 Ϯ 2.5 pF, and the average R s was 6.4 Ϯ 1 (n ϭ 12).
Electrophysiological Methods. Recordings were made with the standard whole-cell voltage-clamp technique (Hamill et al., 1981) . Electrodes were prepared from microcapillary tubes (Drummond Scientific Company, Broomall, PA), coated with Sylgard (Dow Corning, Midland, MI) and fire-polished. Pipette resistances were 2 to 5 M⍀. Voltage commands and digitization of membrane currents were done with Clampex 5.5 of the pClamp software package (Axon Instruments, Foster City, CA) running on an IBM-compatible computer. Membrane currents were recorded with an Axopatch 200A patch-clamp amplifier (Axon Instruments). Typically, cells were held at Ϫ90 mV and depolarized to Ϫ35 mV every 20 s to evoke inward currents. Data were analyzed using Clampfit (Axon Instruments). Currents were filtered at 5 kHz. Reported series resistance values were taken from the reading of the amplifier. In all experiments, series resistance was compensated 60 to 80%. All reported membrane potentials are nominal values. All experiments were done at room temperature (20-23°C). In most experiments, leakage subtraction was achieved with a P/5 on-line subtraction protocol. Error bars indicate standard deviations of multiple determinations obtained from at least five different cells.
Analysis of Current Blockade. The percentage reduction in peak T current at a given blocker concentration was used to generate concentration-response curves. For each concentration-response curve, all points are averages of multiple determinations obtained from at least five different cells. On all plots, vertical bars indicate standard deviation. Mean values on concentration-response curves were fit to the following function:
where PB max is the maximal percent block of peak T current, the IC 50 is the concentration that produces 50% of maximal inhibition, and h is the apparent Hill coefficient for blockade. In the case of isoflurane, because each application of blocker involved a separate determination of anesthetic concentration, all data points were fit with the above function. Fitted values are typically reported with 95% linear confidence limits. Fitting was done with Origin 3.7 (Microcal Software, Northhampton, MA). Solution Exchange Procedures. The solution application system consisted of multiple, independently controlled glass capillary tubes, whereas solution was removed from the other end of the chamber with the use of constant suction. Manually controlled valves accomplished switching between solutions. Test solutions were maintained in closed, weighted all-glass syringes (to avoid saline evaporation and loss of volatile drugs) and allowed to fall by gravity. Changes in Ca 2ϩ current amplitude in response to rapidly acting drugs or ionic changes were typically complete in 10 to 20 s. Switching between separate perfusion syringes, each containing control saline, was without effect on Ca 2ϩ current amplitude. No dependence on the order of presentation or desensitization with repeated applications was observed for any of the pharmacological agents.
Solutions and Current Isolation Procedures. The standard extracellular saline for recording of Ca 2ϩ current contained (in millimolar): 160 TEA-Cl, 10 HEPES, 2 CaCl 2 , adjusted to pH 7.4 with TEA-OH, osmolarity 316 mOsm. Cells were generally maintained in a Tyrode's solution until seal formation, at which time the bath solution was switched to the Ca 2ϩ saline. Internal solution consisted of (in millimolar) 110 Cs-methane sulfonate, 14 phosphocreatine, 10 HEPES, 9 EGTA, 5 Mg-ATP, and 0.3 Tris-GTP, pH adjusted to 7.15 to 7.20 with CsOH (standard osmolarity: 300 mOsm). When this internal saline was used for recording of T current in DRG cells, most of the HVA current in these cells was blocked by preincubating cells with 1 M -CgTx-GVIA, 2 M -CgTx-MVIIC and by including 5 M nifedipine in the external solution to block N, P, Q, and L types of HVA current. Because in control experiments this effect was irreversible for up to 60 min, we routinely preincubated every slide with these toxins and recorded within this time frame. In most cells included in this study, blockade of L-, N-, P-, and Q-type currents was sufficient to allow investigation of T current in virtual isolation. Because of the possibility of some residual HVA current contamination, all measurements of T current amplitude in DRG cells were made from the peak of the inward current to the current remaining at the end of a 200-ms test step. Typically, the residual current at 200 ms was indistinguishable from leak current.
Drugs and Chemicals. -Conotoxin GVIA (-CgTx-GVIA), -conotoxin MVIIC (-CgTx-MVIIC) and tert-butylbicyclo[2.2.2]phosphorothionate (TBPS) were obtained from RBI (Natick, MA), and etomidate powder and isoflurane were obtained from Abbott (Abbott Park, IL). All other chemicals were obtained from Sigma or Aldrich Chemicals (Milwaukee, WI).
Drug Preparation. Stock solutions of propofol (50 mM), etomidate (300 mM), MPS (1 M), TBPS (50 mM), and phenytoin (100 mM) were prepared in dimethyl sulfoxide (DMSO) and kept at 4°C until use. 0.1% DMSO had no effect when tested alone in DRG cells or HEK cells with either ␣1G or ␣1H constructs.
The maximal DMSO concentration used in experiments with ␣1G currents and DRG T currents was 0.6%, and this did not have any effect on inward currents in these cells (n ϭ 4). In HEK cells with ␣1H constructs, 0.3% DMSO reduced current amplitude by 8 Ϯ 3.3% (n ϭ 11), and 0.6% DMSO reduced current amplitudes by 16.8 Ϯ 8% (n ϭ 9). Therefore, we did not use concentrations higher than 0.3% DMSO in our experiments with ␣1H currents. Ethosuximide (ES) and octanol were prepared in extracellular solutions and sonicated. All barbiturates were prepared in stock solutions in 0.1 N TEA-OH; the pH of the final extracellular solution was adjusted with HCl to 7.4. Isoflurane solutions were prepared from saturated saline solutions, and the final concentration in the bath was determined with gas chromatography for each experiment (Evers et al., 1986) . Stocks of other drugs were made by dissolving the compound in either the extracellular saline or distilled water. All test solutions were prepared the day of the experiment by diluting the stock solutions with the appropriate amount of extracellular saline. ES was added to the extracellular saline without osmotic adjustments. In separate control experiments, application of extracellular saline with additional sucrose (100 mM) had no effect on ␣1G-based current amplitude (4.3 Ϯ 1.5% block; mean Ϯ S.D., three cells).
Results
Here, we have studied the effects of anesthetic and anticonvulsant compounds on ␣1G and ␣1H currents in HEK cells. All of the compounds have been previously systematically examined for effects on native T currents in adult rat DRG neurons and, to some extent, on T current in GH3 cells (Herrington and Lingle, 1992) . Some information on the blocking effects of these agents on high-voltage-activated Ca 2ϩ currents is also available, in particular, for blockade of ␣1E current (Nakashima et al., 1998) . For MPS and phenytoin, we describe differences between effects on ␣1G current and previous results on DRG cells . Because we were concerned that the observed differences could be due to the different charge carriers used (10 mM Ba 2ϩ versus 2 mM Ca 2ϩ in this study), we have also repeated pharmacological experiments on DRG neurons under ionic conditions identical with those used to study ␣1G and ␣1H currents.
Effects of Anticonvulsants on ␣1G and ␣1H Current. A number of studies have indicated that various anticonvulsants, including succinimides (Coulter et al., 1989 (Coulter et al., , 1990 ) and phenytoin (Twombly et al., 1988) have blocking effects on T-type Ca 2ϩ current. Work on thalamic relay neurons (Coulter et al., 1989 (Coulter et al., , 1990 suggested that the anticonvulsant drug, ES, was a blocker of T current within clinically effective concentrations. This effect was believed to contribute to its efficacy in petit mal seizures. More recent work now suggests that T current in thalamic neurons is not blocked by ES (Leresche et al., 1998) , and other studies have shown that effects of ES on various T currents only occur at concentrations well beyond those obtained clinically (Herrington and Lingle, 1992; Todorovic and Lingle, 1998) . However, the anticonvulsants, phenytoin and MPS, do have some blocking effects on DRG T currents at clinically relevant concentrations . Furthermore, because of the proposed role of thalamic T currents in the initiation of epileptic activity (Chung et al., 1993; Huguenard and Prince, 1994; Tsakiridou et al., 1995) , the effects of possible effects of anticonvulsants on T current variants remains of interest. Here, we have therefore examined the effects of phenytoin, MPS, and ES on ␣1G and ␣1H currents.
Phenytoin Differentially Affects Native DRG T Current and ␣1G and ␣1H Current. The effect of phenytoin on ␣1G current is illustrated in Fig. 1 . 10 M phenytoin produced a small reduction in ␣1G current (left traces in Fig.  1A ), whereas 300 M phenytoin produced a more complete blockade (right traces in Fig. 1A ). The effects of three different phenytoin concentrations on peak ␣1G current are illustrated in Fig. 1B . The concentration dependence of phenytoin block of ␣1G current is summarized in Fig. 1E , indicating that with sufficiently high concentrations of phenytoin a nearly complete block of ␣1G current can be achieved.
The ability of higher phenytoin concentrations to produce nearly complete block of ␣1G current ( Fig. 1E ) differs from the effect of phenytoin on DRG currents described in our recent work . In the earlier study 10 mM Ba 2ϩ was used as the extracellular permeant ion, whereas here we have used 2 mM Ca 2ϩ to study ␣1G current. Therefore, we re-examined the blocking effects of phenytoin on DRG T current using 2 mM extracellular Ca 2ϩ . We found that the effects of phenytoin on DRG T current with 2 mM Ca 2ϩ as the extracellular permeant cation are essentially identical with previous results with 10 mM Ba 2ϩ . The effect of 10 and 300 M phenytoin on DRG T current is shown in Fig. 1C . 10 M phenytoin produces a larger fractional reduction of DRG T current than of ␣1G current. However, 300 M phenytoin is less effective at blocking DRG T current than ␣1G current (compare Fig. 1C with 1A). The similarity in the blocking effect of 300 and 600 M phenytoin on DRG T current is shown in Fig. 1D . The concentration dependence of the blocking effect of phenytoin on either DRG T current or ␣1G current is shown in Fig. 1E . The DRG T current clearly differs from the ␣1G current in its sensitivity to phenytoin: the DRG T current is inhibited at lower concentrations but is incompletely blocked at the highest concentrations. For DRG T current, the IC 50 was 7.8 Ϯ 1.4 M with a Hill coefficient (h) of 1.9 Ϯ 0.5 and maximal block of 58 Ϯ 3%. For ␣1G current, the IC 50 was 140 Ϯ 65 M (h ϭ 1.2 Ϯ 0.4) with a fitted maximal block of 100 Ϯ 18%. The higher affinity, partial block by phenytoin is similar to its effect on N1E-115 neuroblastoma cells (Twombly et al., 1988) .
Because the ␣1H subunit appears to be the primary T-type current subunit in sensory ganglia (Talley et al., 1999) , we were interested in whether the observed discrepancy in pharmacological sensitivities between DRG T currents and ␣1G currents might reflect the predominance of ␣1H current in DRG cells. Surprisingly, when we examined the effects of phenytoin on ␣1H current in the stably transfected HEK293 cells, phenytoin produced two distinct types of blocking effects on ␣1H current. Figure 2A shows an example of the effect of 10 and 300 M phenytoin on ␣1H currents in a cell (13 of 23 cells) in which increases in phenytoin concentration from 100 to 300 M produced an increase in block (Fig. 2B) , whereas 10 M phenytoin had negligible blocking effects. In contrast, in 10 of 23 cells 10 M phenytoin produced a distinct blocking effect on ␣1H current (Fig. 2C) , whereas blockade by phenytoin appeared to reach a limiting value over the range of 30 to 300 M (Fig. 2D ).
Because phenytoin qualitatively appeared to produce different types of blockade in the two types of cells, we sought criteria that might justify separation of the cells into groups. In one set of experiments, the blocking effects of 10, 30, 100, and 300 M phenytoin were examined. In a subsequent set of experiments, we tested 100, 300, and 600 M. For the first set of cells, for each cell we determined the fold increase in block resulting from increasing the phenytoin concentration from 30 to 300 M. In five of these cells, the increase to 300 M resulted in an increase of 1.2-Ϯ 0.3-fold (mean Ϯ S.D.; maximum increase in any cell: 1.5-fold). In eight other cells, the increase to 300 M resulted in a fold increase of 4.0 Ϯ 1.9 (minimum increase in any cell: 2.7-fold). In a second set of cells, the fold increase block that resulted from raising the phenytoin concentration from 100 to 600 M was determined. For five cells, the fold increase was 1.1 Ϯ 0.3 (maxi- Fig. 1 . The anticonvulsant phenytoin has differential effects on ␣1G current in HEK cells and T currents in native DRG cells. A, traces show block by 10 M phenytoin (left) and 300 M phenytoin (right) of ␣1G current in HEK293 cells. B, plot of a temporal record of the reduction of peak ␣1G current by multiple applications of phenytoin, indicating the substantial difference in block produced by 100 and 300 M phenytoin. Note that 300 M phenytoin almost completely blocks the ␣1G currents. C, traces show block of T currents in DRG currents under ionic conditions identical with those used in A. Left traces show effect of 10 M phenytoin, whereas right trace shows blocking effect of 300 M phenytoin from the same cell. Note that 10 M phenytoin blocked a larger percentage of DRG T current, and 300 M phenytoin blocked less, in comparison to the ␣1G current. D, peak T current amplitude during the course of an experiment on a DRG neuron shows that 300 and 600 M phenytoin produce a similar and partial block. Horizontal bars indicate time of application. E, the concentration dependencies of phenytoin inhibition of DRG T current (filled symbols) and ␣1G current (open symbols) are displayed. Vertical lines indicate SE and solid lines are best fits of eq. 1. For DRG T current, the fitted maximal block is 58% with little difference observed between 30 and 600 M phenytoin. For ␣1G current, nearly 100% block is achieved with 600 M phenytoin with an IC 50 of 124.2 Ϯ 9.1 M (h ϭ 1.4; 7 cells). However, the IC 50 for block of DRG T current (IC 50 of 8.0 Ϯ 2.9 M; h ϭ1.9; 8 neurons) is more than 10-fold less than for block of ␣1G current. M (right) phenytoin on ␣1H current in a cell in which blockade by phenytoin increased substantially over the range of 100 to 300 M. B, the temporal record of the inhibition of peak ␣1H current by phenytoin illustrates the progressive increase in block with increasing concentrations. Horizontal bars indicate time of drug application. C, current traces show effects of 10 (left) and 300 (right) M phenytoin, respectively, on inward ␣1H current in another HEK cell. Note that 10 M phenytoin produced more block (about 25%) and 300 M phenytoin blocked less block (only about 40%) than for the cell in A. D, the temporal record of the effects of phenytoin on peak current for the cell in C shows that for this cell there is little difference in inhibition by phenytoin over the range of 30 to 300 M with maximal block occurring at less than 50%. E, concentration dependencies for block by phenytoin is displayed for the two categories of cells: those in which phenytoin produces a partial, but higher affinity, block (IC 50 ϭ 8.3 M; maximum ϭ 44.8%; n ϭ 10 cells) and those in which phenytoin produces a complete, but lower affinity, block (IC 50 ϭ 192 M; n ϭ 13 cells). F, concentration dependencies of block of ␣1H current by phenytoin are compared with block of DRG current and ␣1G current by phenytoin (from Fig. 1E ).
Block of ␣1G and ␣1H Ca 2؉ Currents by Anticonvulsants and Anesthetics mum increase: 1.6-fold), whereas for another five cells the fold increase was 4.3-Ϯ 1.2-fold (minimum increase: 3.1-fold). Although we cannot completely exclude that, in individual cells, there may be mixtures of pharmacological sensitivities, the groupings just outlined strongly suggest that the ␣1H current in HEK cells exhibits either of two types of sensitivity to phenytoin. The concentration-response curves for phenytoin for both types of block are shown in Fig. 2E . For the lower affinity, but complete, block produced by phenytoin (open symbols), the IC 50 was 192.2 Ϯ 47 M (h ϭ 1.3 Ϯ 0.3). For the partial block of higher affinity, the IC 50 was 8.3 Ϯ 0.4 M (h ϭ 1.1 Ϯ 0.1) with a fitted maximal block of only 44.8 Ϯ 0.5%. The lower affinity, but complete block, by phenytoin closely mirrors the results obtained for block of ␣1G current by phenytoin, whereas the higher affinity, but partial block, is similar to results obtained from native DRG T currents (Fig. 2F) .
Both types of response to phenytoin were observed in the same culture dishes with the same test solutions, and no obvious differences in current properties were noted. For seven cells with a partial block by phenytoin, peak current density (Ϫ35 mV from a holding potential of Ϫ90 mV) was 44.5 Ϯ 8.6 pA/pF (mean Ϯ S.D.), whereas for seven cells with complete block by phenytoin peak current density was 47.5 Ϯ 13 pA/pF. Similarly, there was no difference in the 10 to 90% activation time (7.7 Ϯ 2.5 ms for five cells with partial block, and 7.7 Ϯ 2.7 for five cells exhibiting complete block) or inactivation time constant at Ϫ35 mV (25.4 Ϯ 8.7 ms for five cells with partial phenytoin block and 23.3 Ϯ 4.5 ms for five cells with complete block). Because a different amount of maximal block was observed in the two cases, the results can not be explained as a simple shift in the concentration-response curve due to inadequate exchange of solutions. These results minimally suggest that there is something different about the molecular composition of the T current channels among different ␣1H cells. Given the pharmacological similarity of one subset of ␣1H cells to the DRG neurons and the other ␣1H subset to ␣1G cells, it is suggestive that there is some regulatory factor or additional type of accessory subunit that can associate with ␣1H channels that may be present in DRG cells and also some, but not all, HEK cells.
Effects of Succinimides on ␣1G and ␣1H Current. MPS is another anticonvulsant reported to have only partial blocking effects on DRG T current , although it has been reported to produce complete block of thalamic neuron T current (Coulter et al., 1990) . The effects of 300 M and 3 mM MPS on ␣1G current are shown in Fig. 3A , whereas the effects of four different MPS concentrations on peak ␣1G current are summarized in Fig. 3B . MPS, like phenytoin, appears able to produce a nearly complete block of ␣1G current with sufficiently high concentrations. The IC 50 for block of ␣1G current by MPS was 1.7 Ϯ 0.3 mM (n ϭ 1.7 Ϯ 0.3) with maximal block near 100%.
The effect of MPS on ␣1G current just described using 2 mM Ca 2ϩ as the permeant ion differs from our previous results with MPS on DRG neurons in which 10 mM Ba 2ϩ was employed . Therefore, we reexamined the effects of MPS on DRG T current using 2 mM extracellular Ca 2ϩ . In contrast to the effects of MPS on ␣1G current, there was little difference in the blocking effect of 300 M and 3 mM MPS on DRG T current. The similarity in blocking effectiveness of 1 mM and 3 mM MPS on DRG T current is also summarized in Fig. 3D . For DRG T current, the IC 50 was 190 Ϯ 20 M (h ϭ 1.2 Ϯ 0.5) with a maximal block of only 37 Ϯ 4% similar to our previous measurements (170 M with a maximum of 26%).
We next tested the effects of MPS on ␣1H current. In a set of 19 cells in which the effects of up to 6 mM MPS were examined (Fig. 3E) , MPS produced an almost complete block in all cells with an IC 50 of 2.3 Ϯ 0.4 mM (h ϭ 1.5 Ϯ 0.3). This complete block by MPS was observed both in cells in which phenytoin produced only a partial block and in cells in which phenytoin produced a complete block. A comparison of the concentration dependence of MPS block of the three currents (Fig. 3F) indicates that MPS produces a higher affinity, partial block of DRG T current. This is similar to our previous observations with 10 mM Ba 2ϩ , whereas MPS produces a weaker, more complete block of both ␣1G and ␣1H current. Fig. 3 . MPS produces a low affinity, complete block of ␣1G and ␣1H current, which differs from blockade of DRG T current. A, left and right panels display ␣1G currents blocked by 0.3 and 3 mM MPS, respectively. B, temporal record of the peak current amplitude over the course of an experiment illustrates the concentration dependence of MPS inhibition of ␣1G current. 6 mM MPS produces an almost complete block of ␣1G current. C, left and right panels show examples of the inhibition of DRG T current by 0.3 and 3 mM MPS, respectively. Note that 3 mM MPS produces little additional inhibition over that achieved with 0.3 mM MPS. D, a temporal record of the inhibition of peak DRG T current by 1 and 3 mM MPS shows that MPS maximally blocks only about 30% of the peak current in this case. E, blockade of ␣1H current by 6 mM MPS is illustrated. F, the concentration dependencies of MPS block of DRG T current (filled circles), ␣1G current (open circles), and ␣1H current (diamonds) are displayed. Vertical lines represent S.D. Solid lines are best fits of eq. 1. For MPS inhibition of DRG T current (n ϭ 6 cells), the IC 50 was 0.14 Ϯ 0.1 mM (h ϭ 1.2) with a maximal block of 33%. For inhibition of ␣1G current (n ϭ 5 cells), the IC 50 was 1.7 Ϯ 0.3 mM (h ϭ 1.6) with maximal block constrained to 100%. For ␣1H current (n ϭ 19 cells), the IC 50 was 2.3 Ϯ 0.4 mM (h ϭ 1.5) with maximal block constrained to 100%. 
Downloaded from
We also examined the effects of ES. As shown in Fig. 4A , concentrations of ES well in excess of 1 mM are necessary to produce blockade of ␣1G current, with sufficiently high concentrations of ES producing complete block. Blockade does not result from the osmotic effects of such high concentrations, because equivalent osmotic additions of sucrose have no effects on ␣1G current (not shown). Blockade by ES was readily reversible (Fig. 4B) ; the concentration dependence of the block (Fig. 8E) yielded an IC 50 of 14 Ϯ 3.7 mM (h ϭ 0.9 Ϯ 0.2). ES produced very similar effects on ␣1H current (Fig.  4C, D) with an IC 50 of 22.4 ϩ 3.0 mM (h ϭ 1.5 Ϯ 0.3). Thus, both ␣1G and ␣1H currents are relatively insensitive to ES, similar to other reports of a lack of ES on T current in DRG neurons (Gross et al., 1997; Todorovic and Lingle, 1998) and in thalamic neurons (Leresche et al., 1998) .
Valproic acid (VPA) is an anticonvulsant that produced a 17% reduction of DRG T current at 3 mM in a previous study (see Table 1 of Todorovic and Lingle, 1998) . On ␣1G currents, 1 mM VPA had no effect, and 3 mM VPA blocked only 4.3 Ϯ 3.2% (n ϭ 4 cells). On ␣1H currents, 1 mM VPA reduced peak current by 8.6 Ϯ 2% (n ϭ 3 cells).
Lack of Effect of Convulsants on ␣1G Current. Because thalamic T currents have been proposed to play an important role in the initiation of epileptic activity (Chung et al., 1993; Huguenard and Prince, 1994; Tsakiridou et al., 1995) , we tested two convulsant compounds on ␣1G current. Pentylenetetrazol at 1 mM had no effect on ␣1G current in five cells (4.4 Ϯ 6% inhibition). This was similar to the reported insensitivity to this agent of T current in DRG cells and thalamic cells (Coulter et al., 1990) . TBPS is a potent GABA A receptor antagonist (Casida et al., 1985) . In four HEK cells, 50 M TBPS had no effect on ␣1G current.
Blockade of ␣1G Current by Parenteral Anesthetics and Related Compounds. Various anesthetics have also been reported to inhibit T-type currents in various cells, in some cases at concentrations that overlap their clinical usage. All parental anesthetics used in this study did produce complete block of ␣1G currents and, when tested, complete block of ␣1H currents. Blocking potency was, in general, quite comparable with previous results on T current in DRG neurons.
Octanol is an anesthetic-like agent of interest primarily because of early reports that it potently blocks T currents in inferior olivary neurons (Llinas 1988) and neonatal DRG cells (Scott et al., 1990) . Later reports indicated weaker blocking effects on T currents in GH3 cells (Herrington and Lingle, 1992) and DRG neurons . Figure 5A shows examples of ␣1G currents elicited by voltage steps to Ϫ35 mV before and during application of 0.3 and 1 mM octanol. The peak inward current amplitude during one experiment in which four different concentrations of octanol were applied to a cell is plotted in Fig. 6B , showing the rapid onset of block and complete recovery from block. A characteristic of blockade by octanol was an increase in the apparent rate of current inactivation (Fig. 5C) . Octanol blocked ␣1G current completely with 50% inhibition (IC 50 ) at 160 Ϯ 13 M (h ϭ 1.3 Ϯ 0.1) (Fig. 4C) .
Very similar effects of octanol were observed on ␣1H current (Fig. 6A, B) , including the increase in apparent current inactivation rate in the presence of octanol (Fig. 6A) . Figure  6D compares the effects of octanol on both ␣1G and ␣1H current. For inhibition of ␣1H current, the IC 50 for blockade by octanol was 218.6 Ϯ 44 M (h ϭ 1.4 Ϯ 0.3).
Propofol (2,6-diisopropylphenol) is a frequently used i.v. anesthetic. It blocked ␣1G currents completely with an IC 50 at 20.5 Ϯ 2.0 M (h ϭ 1.4 Ϯ 0.2) (Fig. 5D) . Similarly, propofol blocked ␣1H currents in a reversible fashion (Fig. 6C) with the IC 50 for block of ␣1H current being 27 Ϯ 3 M (h ϭ 1.2 Ϯ 0.2) (Fig. 6D) . Propofol produced no effect on the rate of current inactivation.
Etomidate is also an i.v. general anesthetic. It was also able to inhibit ␣1G currents completely with an IC 50 of 161 Ϯ 46 M (h ϭ 1.7 Ϯ 0.5). Finally, ketamine, an i.v. anesthetic and N-methyl-D-aspartate antagonist, was least potent in blocking ␣1G currents with an IC 50 of 1.2 Ϯ 0.1 mM (h ϭ 1.4 Ϯ 0.1). Effects of etomidate and ketamine on ␣1H current were not determined.
Concentration-response curves for effects of these anesthetics on ␣1G current are summarized in Fig. 5D . The IC 50 values for block of both ␣1G and ␣1H currents are compara- Fig. 4 . The anticonvulsant, ES, blocks ␣1G and ␣1H current similarly. A, traces show block of ␣1G current produced by either 10 and 100 mM ES. B, peak inward current activated every 20 s from the experiment shown in A is plotted as a function of elapsed time. C, traces show block of ␣1H current produced by 100 mM ES. D, peak inward current activated every 20 s from the experiment shown in C is plotted as a function of elapsed time. E, the concentration dependence of ␣1G and ␣1H current reduction by ES is plotted. Each point is the average of the block produced by ES applications to at least five different cells, with vertical lines indicating S.D. Solid lines are best fit of eq. 1, yielding for ␣1G current, an IC 50 of 14 Ϯ 3.7 mM (h ϭ 0.9) with the fit constrained to a maximal block of 100% and, for ␣1H current, an IC 50 ϭ 22.4 Ϯ 3.0 mM (h ϭ 1.5) with maximal block constrained to 100%.
Block of ␣1G and ␣1H Ca 2؉ Currents by Anticonvulsants and Anesthetics ble (e.g., Fig. 6D ) and similar to previously reported values for blockade of DRG T currents as presented in Table 1 . Effects of Isoflurane on ␣1G Current. Volatile anesthetics, like isoflurane and halothane, are reported to block T currents in DRG cells in clinically relevant concentrations . Of the volatile anesthetics that have been tested on T currents, isoflurane appears to have the most pronounced blocking effects at concentrations likely to occur during clinical use . Examples of the effects of isoflurane on ␣1G current are shown in Fig. 7A . Blockade was rapid and readily reversible (Fig. 7B) . At sufficiently high concentrations, isoflurane blocked ␣1G current essentially completely. In all experiments, actual concentrations of isoflurane in the bath were measured using gas chromatographic analysis. Like octanol, but not propofol, isoflurane increased the apparent rate of inactivation of ␣1G current (Fig. 7C) . The concentrationresponse curve for blockade of ␣1G current by isoflurane is shown in Fig. 7D , yielding an IC 50 of 277 Ϯ 24 M and h of 2.2 Ϯ 0.4. This compares to an IC 50 for blockade of DRG T current by isoflurane of 303 M .
Blockade of ␣1G and ␣1H Current by Barbiturates. Barbiturates are interesting compounds, because they are both general anesthetics and antiepileptics. Pentobarbital, methohexital, thiopental, and phenobarbital block DRG T currents in adult rats, although at concentrations higher than those achieved during clinical use .
Examples of the blocking effects of thiopental and phenobarbital on ␣1G currents are shown in Figs. 8A and 8B, respectively, whereas Fig. 8C shows the temporal summary of the effects of multiple barbiturate applications on peak ␣1G current amplitude. Of the barbiturates, thiopental and pentobarbital blocked with similar potency with phenobarbital being less effective. For pentobarbital, blockade occurred with an IC 50 of 310 Ϯ 40 M (h ϭ 1.4 Ϯ 0.2). For thiopental, the IC 50 was 280 Ϯ 40 M (h ϭ 1.2 Ϯ 0.2). For phenobarbital, the IC 50 was 1.54 Ϯ 0.2 mM (h ϭ 1.2 Ϯ 0.2). The concentration-response curves for these three compounds are displayed in Fig. 8D . These values are similar to those previously reported for blockade of DRG T current (see Table 1 ). The barbiturates had no effect on the time constant of inactivation of ␣1G current.
To evaluate the sensitivity of ␣1H current to barbiturates, the ability of pentobarbital to inhibit ␣1H current was examined. Pentobarbital blocked ␣1H current in a manner similar to its effects on ␣1G current (Fig. 8E) with an IC 50 of 345 Ϯ 94 M (h ϭ 1.1 Ϯ 0.2). As with ␣1G current, pentobarbital had no effect on the time constant of ␣1H current inactivation. The similarity of the blocking effect of pentobarbital on both ␣1G and ␣1H current is summarized in Fig. 8F .
It must be noted that, for most compounds, we did not test for voltage or use dependence of block. Substantial voltage or use dependence of block can affect estimated IC 50 values. However, there was no indication of slow block by any of the anesthetic-like compounds we examined.
Discussion
The low threshold for activation of T type Ca 2ϩ currents allows them to play a critical role in the regulation of cellular excitability, both in neurons and other cell types (Huguenard, 1996) . Despite general similarity among various T-type currents in different cells, some differences in kinetic behaviors and pharmacological sensitivities have been observed (Huguenard, 1996) . With the availability of cloned T-type current variants Perez-Reyes et al., 1998; Lee et al., 1999a) , it is now possible to examine physiological and pharmacological properties of T currents of defined molecular components. Here, we have examined the sensitivity of cloned T-type current variants to anticonvulsants and anesthetics. The results suggest that, although anesthetic sensitivity does not vary among DRG, ␣1H, and ␣1G currents, blocking effects of some anticonvulsants may depend on specific subunits contributing to the T channel.
Blockade of T Current by Anticonvulsants. Interest in the possible role of T current inhibition in the action of anticonvulsants arose from reports that ES and MPS may inhibit T current in thalamic relay neurons (Coulter et al., 1989 (Coulter et al., , 1990 . These succinimide compounds belong to a class 
of anticonvulsants used to treat petit mal-generalized absence seizures (Macdonald and McLean, 1986) . However, although some results support a potential contributory role of T current in experimental models of epilepsy (Chung et al., 1993; Tsakiridou at el., 1995) , more recent work indicates that 1 mM ES does not inhibit T current on thalamic cells (Leresche et al., 1998) . The lack of effect of ES on thalamic T currents is comparable with the relative insensitivity (IC 50 values greater than 10 mM) of native T currents (Herrington and Lingle, 1992; Todorovic and Lingle, 1998) and ␣1G and ␣1H current that we observe. The results would suggest that the anticonvulsant action of ES is unlikely to arise from effects on T-type currents. In contrast to ES, some blockade by MPS of both native and cloned T-type channels is expected at therapeutically relevant concentrations [ϳ50-200 M: Strong et al. (1974) ]. Studies in thalamic neurons reported that MPS blocked T currents completely with an IC 50 of 1.1 mM (Coulter et al., 1990) . In agreement with these results, we find that MPS blocked ␣1G currents completely with similar potency, consistent with the view that ␣1G is the predominant isoform expressed in thalamic relay nuclei (Talley et al., 1999) .
The most interesting aspect of our results is the selectivity of phenytoin among different T current variants and the selectivity of MPS between the cloned T current variants and the native DRG T current. Specifically, DRG T current exhibits a higher affinity, partial block by both phenytoin and MPS, whereas ␣1G current is completely blocked by both anticonvulsants, although with lower affinity. Thus, DRG T current is pharmacologically distinct from ␣1G current. Furthermore, ␣1H current exhibits a mixed sensitivity to phenytoin with both partial, higher affinity block in some cells, and complete, lower affinity block in others.
Because the ␣1H channel variant is thought to be more abundant in sensory ganglia than either the ␣1G or ␣1I variants (Lee et al., 1999a) , a difference in the pharmacological sensitivities of ␣1G and native DRG T currents might be attributable to a greater abundance of the ␣1H channel in DRG cells. In support of this hypothesis, Ni 2ϩ was found to block cloned ␣1H currents (Lee et al., 1999b) at similar concentrations as it blocks DRG T currents , whereas 40-fold higher concentrations are required to block ␣1G and ␣1I currents. However, the present results show that the pharmacological properties of neither ␣1G nor ␣1H currents correspond fully with the properties of DRG T current. Specifically, blockade of DRG T current by A, traces display inward currents activated by a 200-ms voltage step from Ϫ90 mV to Ϫ35 mV before, during, and after application of 0.3 and 1 mM octanol. Note the faster rate of inactivation in the presence of 300 M octanol. B, peak inward current over the course of the experiment for the cell shown in A is displayed to illustrate the concentration dependence and reversible nature of block by octanol. Currents were activated every 20 s. Horizontal bars indicate time of application of the indicated concentrations of octanol. C, the decay phase of normalized currents before, during, and after application of 300 M octanol are shown to illustrate the effect of octanol on current inactivation rate. Inactivation time constants were 10.7, 5.5, and 10.4 ms before, during, and after octanol application, respectively, from single exponential fits to the current decay phase. D, average concentration-response curves for blockade of peak ␣1G current by propofol, etomidate, ketamine, and octanol. Block of ␣1G and ␣1H Ca 2؉ Currents by Anticonvulsants and Anesthetics MPS differs from block of both ␣1G and ␣1H current. Similarly, the results with phenytoin do not demonstrate a simple equivalence of either the ␣1G or ␣1H currents with the DRG currents. Thus, our results lead us to suggest that DRG neurons may contain either additional regulatory subunits that alter the pharmacological properties of ␣1G or ␣1H channels or that native ␣1G or ␣1H subunits may undergo post-translational modifications that distinguish them from their properties in expression systems. The pharmacological heterogeneity of ␣1H currents to phenytoin may also be most easily explained by this hypothesis. The correspondence of the DRG T current to one type of ␣1H subtype and the correspondence of the ␣1G current to the other ␣1H subtype might result from some additional molecular component, perhaps an accessory subunit, present in DRG cells and some HEK293 cells. The pharmacological uniformity of the ␣1G currents, in contrast to that of the ␣1H currents, would suggest that any such accessory subunit may selectively influence only the ␣1H subunit.
Although the subunit composition of native T-type channels has not been determined, studies with cloned subunits indicate that ␣2␦-1 can increase the expression of ␣1G in COS cells and Xenopus oocytes (Dolphin et al., 1999) . The effect of ␣2␦-1 was to increase the expression of ␣1G immunoreactivity at the plasma membrane and to increase the ␣1G-mediated currents. No effect was observed on the biophysical properties of the currents. Many studies with HVA channels have also reported that ␣2␦ simply scales the expressed current, although in some cases it appears to affect inactivation kinetics (reviewed in Walker and De Waard, 1998) . In addition, ␣2␦ has been shown to modulate the pharmacology of cloned L-type Ca 2ϩ channels (Wei et al., 1995) . Therefore, it is possible that endogenous ␣2␦ subunits modulate the apparent pharmacological properties of ␣1H in a subpopulation of the stably transfected cell line. Recent work with the ␣1I subunit indicates that physiological properties of this T-type channel differ markedly dependent on whether the subunit is expressed in HEK293 cells or Xenopus oocytes (Lee et al., 1999a) . This result was used to argue for the possible existence of an unknown accessory subunit, Fig. 7 . Isoflurane blocks ␣1G currents at concentrations likely to occur in clinical usage. A, traces show currents activated by voltage steps to Ϫ35 mV in the presence and absence of isoflurane. Concentrations were determined by gas chromatography (Evers et al., 1986) . Similar to octanol, isoflurane increased the current inactivation rate. B, a temporal record of the effects of three concentrations of isoflurane on peak ␣1G current for the cell shown in A is plotted. Open circles represent peak current evoked every 20 s. C, the effect of 410 M isoflurane on the normalized time course of current inactivation is shown. i was 17.7, 8.2, and 15.2 ms for control, 410 M isoflurane, and following wash. D, percent blockade of peak ␣1G current is plotted as a function of isoflurane concentration for isoflurane applications to six cells. All isoflurane values were determined by gas chromatography. The solid line is the best fit of eq. 1 yielding an IC 50 of 262 Ϯ 16.6 M and h of 2.3 Ϯ 0.3 with maximal block constrained to 100%. present in one or the other of the two expression systems, which affects the gating properties of the ␣1I subunit. A similar phenomenon may account for the differences in sensitivity of ␣1H currents to phenytoin.
The ability of anticonvulsants to differentiate among T current variants may have important clinical implications. Phenytoin is used for treatment of generalized tonic-clonic seizures (Macdonald and McLean, 1986 ) and for treatment of neuropathic pain (McQuay et al., 1995) . The higher affinity, partial blockade of DRG, and ␣1H T current occurs within clinically relevant concentrations . In contrast, the lower affinity effect of phenytoin on ␣1G current suggests that some native T currents may be unaffected by this compound during clinical usage. The clinical consequences of phenytoin may, in part, involve an ability to selectively affect particular T current subtypes. Similar arguments apply to MPS.
Blockade of T currents Arising from ␣1G and ␣1H Subunits by General Anesthetics. Anesthetics and anesthetic-like compounds blocked all three T-type currents similarly and are of limited utility in distinguishing among Ttype currents. Table 1 shows the sensitivity of cloned ␣1E currents to these same compounds (Nakashima et al., 1998) , indicating that anesthetics are relatively ineffective in distinguishing between T-type current and at least one type of HVA Ca 2ϩ current. Some general anesthetics, e.g., isoflurane and, to a lesser extent, halothane, block native DRG T currents at concentrations that probably occur during anesthesia . Similar to its effects on DRG T current, isoflurane could completely block ␣1G current with an IC 50 of 271 M. This concentration is less than the reported MAC (minimum alveolar concentration producing anesthesia in 50% of subjects) value of 400 M for this anesthetic (Franks and Lieb, 1994) . This argues that some inhibition of DRG T current and also any T current-containing ␣1G subunits will certainly occur during isoflurane-induced anesthesia. However, except for isoflurane, it appears unlikely that blockade of native T-type currents participates in the clinical effects of other anesthetic agents examined here.
An interesting feature of the anesthetic-like compounds is that two categories of blocking mechanism may occur. Isoflurane and octanol share an ability to alter the rate of ␣1G or ␣1H current inactivation. Halothane and octanol produce similar increases in current inactivation rate on native GH3 T currents (Herrington et al., 1991; Herrington and Lingle, 1992) . In contrast, other anesthetics, including the barbiturates and propofol, produce no alteration in the time course of ␣1G, ␣1H, or DRG T current. This suggests that blockade of T current by the anesthetic compounds can occur by either of two types of mechanism, either of which can produce complete inhibition of T current.
In summary, we have examined the sensitivity of ␣1G and ␣1H T-type currents to a number of anesthetic and anticonvulsant agents. The results indicate that blockade of some T currents may participate in the clinical actions of some agents (isoflurane, MPS, phenytoin). The differential blocking effects of phenytoin and MPS between ␣1G current and native DRG T current, which for phenytoin was also mirrored between subsets of ␣1H-expressing HEK293 cells, argue that some additional factor, perhaps an unknown accessory subunit, may influence the sensitivity of T-type channels to pharmacological agents.
